Canaccord Genuity Reiterates a 'Buy' on OraSure Technologies (OSUR); HCV Study May Boost Guidelines
Go back to Canaccord Genuity Reiterates a 'Buy' on OraSure Technologies (OSUR); HCV Study May Boost Guidelines| OraSure Technologies, Inc. (NASDAQ: OSUR) | Delayed: 3.83 +0.09 (2.41%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.74 | 52 Week High | $9.05 | |||
| Open | $3.78 | 52 Week Low | $5.10 | |||
| Day High | $3.86 | P/E | N/A | |||
| Day Low | $3.72 | EPS | $-0.20 | |||
| Volume | 363,941 | |||||
